Dr. Jennifer Walden Practice Aesthetic Plastic Surgery as a Passion

Dr. Jennifer Walden is female cosmetic surgeon based in Austin, TX, and she is board-certified by the American Board of Plastic Surgery. She mostly specializes in aesthetic, breast, and facial surgeries and conducts a large number of breast augmentation and facial procedures including nose job. She was born in Austin, Texas and both her parents were in the medical field. Her father was a dentist, and her mother was a surgical nurse. She went to Anderson High School and later on joined the University of Texas where she obtained her undergraduate degree in Biology. Jennifer Walden applied for medical school at the University of Texas Medical Branch, and she received Medical Doctorate with Highest Honors. Her performance at the school was exemplary, and she graduated as a salutatorian of her class and more information click here.

She is very dedicated to her job, and this has seen her been awarded various awards including the American Society for Aesthetic Plastic Surgery Award after clinching the position in a scientific exhibit. She was awarded The Janet M. Glasgow Memorial Award in 1998 and several others from distinguished medical organizations. After completing her residency training, she relocated to New York to specialize her interest in aesthetic surgery. Her passion and experience in this field continued while at Manhattan Eye, Ear, and Throat Hospital after interacting with expertise who practiced aesthetic cosmetic surgery and what Walden knows.

Dr. Jennifer Walden has moved back to Austin, and she is running her busy cosmetic surgery practice. She has always loved Austin, mainly because she felt it was the best place for her twin boys to grow in. She serves as a member of the board of directors for American Society for Aesthetic Plastic Surgery. She is also mandated as the media spokesperson for the same organization. In her practice, every effort is carried out to ensure that patients make clear and informed decisions to achieve the most natural results possible. Her primary aim is to make her clients look and feel best through offering the highest level of patient care and safety and Walden’s lacrosse camp.

Other Reference: http://kristingunn.com/dr-jennifer-walden/

Why Life Line Screening is an Ideal Provider of Preventative Care

Findings from the Centers for Disease Control and Prevention (CDC) state that nearly 2.6 million individuals die yearly in the US. Unfortunately, close to seven out of ten of these deaths are caused by chronic illnesses that could have possibly been prevented. Thanks to modern proactive or preventative care measures such as ultrasounds, vascular tests and blood tests among others, serious health problems can be avoided.

Preventative care services, similar to the ones offered by Life Line Screening, help to avert costly and severe health issues waiting to happen in future. Mainly this is because diseases can be detected at early stages and treated before they develop. Additionally, these services can allow you to make simple lifestyle alterations upon identifying various health risk factors in a bid to prevent the spread or development of certain health issues.

Life Line Screening aims at identifying the tests that are most beneficial and important to each person depending on his or her family history, age, medical background and general health risk profile. Tests included in the company’s comprehensive screening program include a limited electrocardiograph, finger-stick blood screening and ultrasound screening.

Life Line Screening

Life Line Screening serves as a foremost provider of community-based preventative health screenings. The company has dedicated itself to the provision of healthy knowledge to help people lead healthier lives. Life Line Screening does this by providing reliable, affordable preventative screenings. This endeavor is driven by the company’s belief that partnering with physicians to detect health issues early enough serves as an effective way to boost the quality of life and learn more about Life Line Screening.

Life Line Screening conducts its screenings through licensed and highly trained healthcare experts. They utilize the same kind of quality equipment available in hospitals. Board-certified healthcare professionals analyze the results found from all the screenings performed. By sharing the results with your doctor, you can embark on treatment and lifestyle changes, where necessary, to avert severe health issues and more information click here.

More Visit: https://www.inc.com/profile/life-line-screening

Amicus Seeks Cures For Many Orphan and Rare Diseases

Amicus Therapeutics, created to find a cure for orphan diseases, was founded in Cranbury NJ in 2002. After five years of private research, Amicus Therapeutics went public. In 2008, the therapeutics company opened a branch in San Diego, California. Amicus presently has locations in Germany, Spain, France, the Netherlands, the United Kingdom, and Italy. The research company relies on many donations from fundraising organizations that include a $210,300 grant from the Alzheimer’s Drug Discovery Foundation and a $500,000 grant from the Michael J Fox Foundation, known for treating Parkinson’s.

Recently, Amicus Therapeutics (:Small Biotech Seems To Have The ‘Big Mo’) is working on treatment for Fabry disease. Fabry disease is damage to the peripheral nerve fibers that can effect the GI tract, including the kidneys and the heart. It can be diagnosed early in childhood. Fabry disease is considered a lysomage storage disorder. Before Amicus Therapeutics came along, Fabry disease was a fatal disease. Marlou from the Netherlands suffers from Fabry disease that took the life of her grandmother. Marlou’s sister, mother, and aunt currently suffer from Fabry disease. In the Netherlands, it was wrongly assumed that women can only carry Fabry disease and not get it. Marlou knows this isn’t true. A sufferer herself, she isn’t going to let this disease stop her from enjoying life. She’s being treated with Migalistat.

Amicus is working with genetic diseases by researching how to target mutated proteins. In 2007, Mike from Saddlebrook, New Jersey, had a breathing problem that was misdiagnosed. Finally, in 2016 doctors learned he had Pompe disease that is a form of muscular dystrophy. MD has similar symptoms as Polymiositis, also a muscular disease. If Mike hadn’t been diagnosed with Pompe disease and received treatment, he might have died.

Amicus Therapeutics has a patient advocacy program that not only treats these rare, orphan diseases, it also educates the patient to help in treatment. In fact, Amicus is at the forefront of treating orphan diseases. Amicus is the first pharmeceutical company to market therapy for Epidermolysis, a muscular connective tissue disease. The pharmeceutical company is working on chaperone-Advanced Replacement therapy for the many of the orphan and rare diseases.

 
Need more information on Amicus Therapeutics? Visit: https://www.glassdoor.com/Reviews/Amicus-Therapeutics-Reviews-E26068.htm

Troy McQuagge the USHEALTH Group CEO Who was recognized by Planet Awards for Being Excellent in Business Leadership

USHEALTH Group has always stood out as the leading company in providing health care insurance to clients all over the world. The company could not have been successful without quality leadership. Tony McQuagge has been the firm’s CEO since 2010; he has delivered excellent services throughout his time. From his excellence Troy has been recognized as Chief Executive Officer of the year by One Planet Awards, he was the gold winner, and the price has built his reputation as well as the company. The awards recognize players in different sectors of the economy from all over the world and to receive any of the prizes a vigorous vetting process is conducted to ascertain that the person receiving the award deserves. Troy McQuagge was incredibly honored and it has shown the whole world that he is a great business leader and read full article.

Troy McQuagge joined the firm when its distribution channels were not very active; to ensure that the company succeeds Troy first rebuilt its distribution agency. It is from this ability to restructure the firm that Troy was named as the Enterprise President and CEO. Through Troy’s leadership, the company has been able to achieve great success and to compete with the largest health insurance firms around the globe. In his acceptance speech for the award, he said that the award was not his rather than the company’s at large. USHEALTH Health Group has gained popularity since Troy got the award and he is laying strategies to open more branches across the world.

The health care sector has faced a lot of challenges and Troy’s aim is to make USHEALTH group the most affordable firm offering clients health insurance. The company serves business people and employed individuals. The company’s head offices are in Texas, with a dedicated team of employees the company has been able to offer customer friendly services.

Troy McQuagge studied at the prestigious University of Central Florida where he graduated with a degree in Legal Studies. Troy has worked in the health insurance industry for many years and the experience he acquired has been very paramount for USHEALTH Group. His first company to work for was Allstate Insurance in 1983 and 1995 he moved Health Market and follow Troy of Twitter.

The Contribution Jeanmarie Guenot has Made in the Pharmaceutical and Biotechnology Industry

Jeanmarie Guenot is a business executive in the pharmaceutical and biotechnology industry. Guenot currently serves as the President and CEO of Amphivena Therapeutics in San Francisco, CA. Guenot has vast knowledge and over 20 years of experience in dealing with cardiovascular diseases neurology, ophthalmic and autoimmune diseases, and oncology. Jeanmarie Guenot graduated from the University of California, San Francisco in 1993 with a Ph.D. and studied her MBA at the University of Pennsylvania, Wharton School. Her extensive knowledge in medicinal and physical knowledge with specialties in quantum mechanical and semi-empirical methods have seen her hold various executive positions in various companies.

 

 

Career Background

 

 

LinkedIn shows us that Guenot has previously worked in different private and public companies in the pharmaceuticals, venture capitals, and business development sectors. After completion of her Ph.D. degree, Jeanmarie Guenot started her career in science at Hoffman- La Roche in 1993 as the principal scientist in Preclinical R&D. She later engaged in a business career at the Atlas Venture. At the company, she was in charge of the venture capital investment management and helped in building life science companies. Guenot was the vice president of PDL BioPharma and Managing Partner at Guenot LLC. In 2009, she founded SKS Ocular LLC, a biopharmaceutical company in San Diego, CA.

 

 

Amphivena Therapeutics

 

 

As the CEO of Amphivena Therapeutics, Guenot has led the company in developing bi-functional antibody therapies in the treatment of the hematological malignancies. The company has developed drugs such as the CD3 and the AMV-364 for the treatment of myeloid leukemia. The pharmaceutical company aims at developing drugs that restore the cellular balance in patients facing life-threatening diseases.

 

 

Significant Accomplishments at PDL BioPharma

 

 

Guenot played an important part at PDL BioPharma for the five years that she was the vice president in Business Development. Her role in the company included alliance management of profit and losses, licensing, as well as mergers and acquisitions. Guenot also licensed Ophthotech for the ophthalmic indication on the oncology drug. She contributed greatly to the co-development and co-commercialization collaboration between PDL and Biogen Idec. The $800M transaction involved three Phase 2 Cancer Patients and autoimmune drug candidates.